These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9890001)

  • 41. Functional receptor for GDNF encoded by the c-ret proto-oncogene.
    Trupp M; Arenas E; Fainzilber M; Nilsson AS; Sieber BA; Grigoriou M; Kilkenny C; Salazar-Grueso E; Pachnis V; Arumäe U
    Nature; 1996 Jun; 381(6585):785-9. PubMed ID: 8657281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.
    Arighi E; Popsueva A; Degl'Innocenti D; Borrello MG; Carniti C; Perälä NM; Pierotti MA; Sariola H
    Mol Endocrinol; 2004 Apr; 18(4):1004-17. PubMed ID: 14715928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Point nucleotidic changes in both the RET proto-oncogene and the endothelin-B receptor gene in a Hirschsprung disease patient associated with Down syndrome.
    Sakai T; Wakizaka A; Nirasawa Y; Ito Y
    Tohoku J Exp Med; 1999 Jan; 187(1):43-7. PubMed ID: 10458491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.
    Eng C; Mulligan LM
    Hum Mutat; 1997; 9(2):97-109. PubMed ID: 9067749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.
    Kurokawa K; Iwashita T; Murakami H; Hayashi H; Kawai K; Takahashi M
    Oncogene; 2001 Apr; 20(16):1929-38. PubMed ID: 11360177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotype variation in two-locus mouse models of Hirschsprung disease: tissue-specific interaction between Ret and Ednrb.
    McCallion AS; Stames E; Conlon RA; Chakravarti A
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1826-31. PubMed ID: 12574515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation.
    Hayashi Y; Iwashita T; Murakamai H; Kato Y; Kawai K; Kurokawa K; Tohnai I; Ueda M; Takahashi M
    Biochem Biophys Res Commun; 2001 Mar; 281(3):682-9. PubMed ID: 11237712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma].
    Fehmann HC; Göke B
    Z Gastroenterol; 1994 Jul; 32(7):416-7. PubMed ID: 7975780
    [No Abstract]   [Full Text] [Related]  

  • 50. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.
    Ivanchuk SM; Myers SM; Eng C; Mulligan LM
    Hum Mol Genet; 1996 Dec; 5(12):2023-6. PubMed ID: 8968758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutational analysis of RET/GDNF/NTN genes in children with total colonic aganglionosis with small bowel involvement.
    Inoue K; Shimotake T; Iwai N
    Am J Med Genet; 2000 Aug; 93(4):278-84. PubMed ID: 10946353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [From monogenic to polygenic: model of Hirschsprung disease].
    Salomon R; Amiel J; Attié T; Pelet A; Munnich A; Lyonnet S
    Pathol Biol (Paris); 1998 Nov; 46(9):705-7. PubMed ID: 9885824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B.
    Cosma MP; Panariello L; Quadro L; Dathan NA; Fattoruso O; Colantuoni V
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):397-400. PubMed ID: 8670046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
    Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
    Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The RET C620S mutation causes multiple endocrine neoplasia type 2A (MEN2A) but not Hirschsprung disease (HSCR) in a family cosegregating both phenotypes.
    Fernández RM; Antiñolo G; Eng C; Borrego S
    Hum Mutat; 2003 Nov; 22(5):412-5. PubMed ID: 14517954
    [No Abstract]   [Full Text] [Related]  

  • 56. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.
    Melillo RM; Santoro M; Ong SH; Billaud M; Fusco A; Hadari YR; Schlessinger J; Lax I
    Mol Cell Biol; 2001 Jul; 21(13):4177-87. PubMed ID: 11390647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.
    Kusafuka T; Puri P
    Pediatr Surg Int; 1997; 12(1):11-8. PubMed ID: 9035202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The GDNF family: from neurotrophic factors to oncogenesis].
    Poteriaev DA; Saarma M
    Mol Biol (Mosk); 2001; 35(2):309-20. PubMed ID: 11357413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kidney development: regulatory molecules crucial to both mice and men.
    Bates CM
    Mol Genet Metab; 2000; 71(1-2):391-6. PubMed ID: 11001832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.